EGLN1
EGLN1, also known as PHD2, SM-20, HIFPH2, ZMYND6 and C1orf12, is a cellular oxygen sensor that hydroxylates proline residues in hypoxia-inducible factor (HIF) alpha proteins. Under normal oxygen levels this modification marks HIF for proteasomal destruction. Browse Assay Genie's current range of EGLN1 research reagents below, or read on for the biology behind the target.
EGLN1 (egl-9 family hypoxia inducible factor 1) is a cellular oxygen sensor. Under normoxic conditions it catalyses the post-translational formation of 4-hydroxyproline in HIF alpha proteins. It hydroxylates a specific proline in each of the oxygen-dependent degradation (ODD) domains of HIF1A, the N-terminal NODD and the C-terminal CODD, and it also hydroxylates HIF2A. It shows a preference for the CODD site. Target proteins are preferentially recognised through an LXXLAP motif.
Hydroxylated HIFs are targeted for proteasomal degradation by the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions the hydroxylation reaction is attenuated. HIFs then escape degradation, translocate to the nucleus, heterodimerise with HIF1B and drive increased expression of hypoxia-inducible genes. HIF is a transcriptional complex with a central role in mammalian oxygen homeostasis, and prolyl hydroxylation is a key regulatory event in controlling its subunits. The EGLN1 protein is the most important isozyme under normoxia and, by regulating HIF1 stability, is involved in hypoxia-influenced processes such as angiogenesis in the retina and cardiac functionality.
The EGLN1 gene belongs to the Egl-9 family of hypoxia inducible factors, and HGNC also places it in the MYND-type zinc finger group. The protein is found in the cytoplasm and nucleus. Earlier names refer to the C. elegans egl-9 homologue. Mutations in the gene are associated with familial erythrocytosis type 3 (ECYT3). Mouse and rat orthologues are both designated Egln1, and related family members include EGLN2 and EGLN3.
EGLN1 acts as the oxygen sensor that sets HIF alpha stability, making it a central subject in studies of the cellular response to low oxygen.
Its hydroxylation of HIF1A and HIF2A prolines links oxygen availability to von Hippel-Lindau-dependent proteasomal degradation of HIF.
By controlling HIF1 stability, EGLN1 is involved in hypoxia-influenced processes including retinal angiogenesis and cardiac functionality.
Mutations in the EGLN1 gene are associated with familial erythrocytosis type 3, making it relevant to studies of inherited red cell disorders.
EGLN1 is a cellular oxygen sensor. In normoxia it hydroxylates specific prolines in HIF alpha proteins, including HIF1A and HIF2A, which targets them for proteasomal degradation via the von Hippel-Lindau complex. In hypoxia this activity falls, so HIFs accumulate and activate hypoxia-inducible genes.
EGLN1 is also called PHD2, SM-20, HIFPH2, ZMYND6 and C1orf12. The UniProt name is Egl nine homolog 1, and earlier HGNC names refer to the C. elegans egl-9 homologue. These names refer to the same gene, and the enzyme is classified as EC 1.14.11.29.
Mouse and rat both carry an orthologue named Egln1. In humans, mutations in the EGLN1 gene are associated with familial erythrocytosis type 3 (ECYT3). Check the datasheet of any product for its validated reactivity.
Other members of the Egl-9 family of HIF prolyl hydroxylases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9GZT9; product specifications from Assay Genie datasheets.